303 related articles for article (PubMed ID: 30541185)
21. [A severe cutaneous anthrax case complicated with sepsis in Bursa, Turkey].
Durmuş G; Yeşilyurt M; Karagöz A; Demir C; Eren N; Kılıç S
Mikrobiyol Bul; 2013 Jul; 47(3):529-37. PubMed ID: 23971931
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods.
Luna VA; King DS; Gulledge J; Cannons AC; Amuso PT; Cattani J
J Antimicrob Chemother; 2007 Sep; 60(3):555-67. PubMed ID: 17586563
[TBL] [Abstract][Full Text] [Related]
23. Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.
Louie A; VanScoy BD; Brown DL; Kulawy RW; Heine HS; Drusano GL
Antimicrob Agents Chemother; 2012 Mar; 56(3):1229-39. PubMed ID: 22155821
[TBL] [Abstract][Full Text] [Related]
24. Anthrax: an update.
Kamal SM; Rashid AK; Bakar MA; Ahad MA
Asian Pac J Trop Biomed; 2011 Dec; 1(6):496-501. PubMed ID: 23569822
[TBL] [Abstract][Full Text] [Related]
25.
Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic susceptibility and molecular diversity of Bacillus anthracis strains in Chad: detection of a new phylogenetic subgroup.
Maho A; Rossano A; Hächler H; Holzer A; Schelling E; Zinsstag J; Hassane MH; Toguebaye BS; Akakpo AJ; Van Ert M; Keim P; Kenefic L; Frey J; Perreten V
J Clin Microbiol; 2006 Sep; 44(9):3422-5. PubMed ID: 16954291
[TBL] [Abstract][Full Text] [Related]
27. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
[TBL] [Abstract][Full Text] [Related]
28. A rapid antimicrobial susceptibility test for Bacillus anthracis.
Weigel LM; Sue D; Michel PA; Kitchel B; Pillai SP
Antimicrob Agents Chemother; 2010 Jul; 54(7):2793-800. PubMed ID: 20439614
[TBL] [Abstract][Full Text] [Related]
29. Selection of Bacillus anthracis isolates resistant to antibiotics.
Athamna A; Athamna M; Abu-Rashed N; Medlej B; Bast DJ; Rubinstein E
J Antimicrob Chemother; 2004 Aug; 54(2):424-8. PubMed ID: 15205405
[TBL] [Abstract][Full Text] [Related]
30. Bacillus anthracis and antibacterial agents.
Bryskier A
Clin Microbiol Infect; 2002 Aug; 8(8):467-78. PubMed ID: 12197869
[TBL] [Abstract][Full Text] [Related]
31. Using old antibiotics to treat ancient bacterium-β-lactams for Bacillus anthracis meningitis.
Sittner A; Ben-Shmuel A; Glinert I; Bar-David E; Schlomovitz J; Kobiler D; Weiss S; Levy H
PLoS One; 2020; 15(2):e0228917. PubMed ID: 32053632
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.
Louie A; Vanscoy BD; Heine HS; Liu W; Abshire T; Holman K; Kulawy R; Brown DL; Drusano GL
Antimicrob Agents Chemother; 2012 Jan; 56(1):513-7. PubMed ID: 22064542
[TBL] [Abstract][Full Text] [Related]
33. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):960. PubMed ID: 11708594
[TBL] [Abstract][Full Text] [Related]
34. Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019.
Maxson T; Kongphet-Tran T; Mongkolrattanothai T; Travis T; Hendricks K; Parker C; McLaughlin HP; Bugrysheva J; Ambrosio F; Michel P; Cherney B; Lascols C; Sue D
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S373-S378. PubMed ID: 36251548
[TBL] [Abstract][Full Text] [Related]
35. MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest.
Turnbull PC; Sirianni NM; LeBron CI; Samaan MN; Sutton FN; Reyes AE; Peruski LF
J Clin Microbiol; 2004 Aug; 42(8):3626-34. PubMed ID: 15297508
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiology of Bacillus anthracis: determining the correct origin.
Pilo P; Perreten V; Frey J
Appl Environ Microbiol; 2008 May; 74(9):2928-31. PubMed ID: 18326672
[TBL] [Abstract][Full Text] [Related]
37. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.
Cavallo JD; Ramisse F; Girardet M; Vaissaire J; Mock M; Hernandez E
Antimicrob Agents Chemother; 2002 Jul; 46(7):2307-9. PubMed ID: 12069996
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibility of Bacillus anthracis.
Doğanay M; Aydin N
Scand J Infect Dis; 1991; 23(3):333-5. PubMed ID: 1909051
[TBL] [Abstract][Full Text] [Related]
40. Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon.
Klee SR; Ozel M; Appel B; Boesch C; Ellerbrok H; Jacob D; Holland G; Leendertz FH; Pauli G; Grunow R; Nattermann H
J Bacteriol; 2006 Aug; 188(15):5333-44. PubMed ID: 16855222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
